MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097147 A) filed by Arnay Sciences, Llc, Shrewsbury, U.S.A., on Oct. 8, for 'delivery of rna therapeutics using circular prodrug nucleic acids.'
Inventor(s) include Agrawal, Sudhir.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides oligonucleotides referred to as circular prodrug nucleic acid ("CPN") as described herein, compositions comprising same, and methods of using same. This design of circular prodrug nucleic acids maintains a circular form until the circularizing domain is cleaved in situ by RNase H or D...